CRISPR THERAPEUTICS
CRISPR Therapeutics AG
Application Filed: 2018-04-11
Trademark Application Details
NON-FINAL ACTION - MAILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87872064 |
| Registration Number | 6055218 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Attorney Name | Christina M. Licursi |
| Attorney Docket Number | C15422000100 |
| Law Office Assigned | M40 |
| Employee Name | SCHIMPF, TIMOTHY O |
Timeline
| 2013-11-00 | Date of First Use |
| 2018-04-11 | Application Filed |
| 2018-08-07 | Location: TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED |
| 2018-08-07 | Status: Live/Pending |
| 2019-01-08 | Transaction Date |
| 2020-05-12 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  CRISPR Therapeutics AG |
| Entity Statement | aktiengesellschaft |
| Address | Aeschenvorstadt 36 Basel CH 4051 |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260903 | Incomplete squares; Squares, incomplete |
| 261121 | Rectangles that are completely or partially shaded |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 41 |
| U.S. Codes: | 100,101,107 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders; reagents for scientific and research use; kits primarily composed of reagents for scientific and research use; laboratory apparatus and instruments for preparing and processing genetic materials in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; gene editing; research and development of therapeutics using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting therapies to individuals; providing education in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy |
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-04-19 | 1 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2018-04-20 | 2 MDSC E:E-Mail |
| ASSIGNED TO EXAMINER | 2018-07-31 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-08-07 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2018-08-07 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-08-07 | 6 GNRN O:Outgoing Correspondence |
| TEAS REQUEST TO DIVIDE RECEIVED | 2019-02-07 | 7 ERTD I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-02-07 | 8 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2019-02-12 | 9 ALIE A:Allowance for Publication |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-02-13 | 10 AITU A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-02-07 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-02-21 | 12 TEME I:Incoming Correspondence |
| DIVISIONAL REQUEST RECEIVED | 2019-02-07 | 13 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2019-02-21 | 14 DPCC D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2019-03-13 | 15 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2019-03-13 | 16 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-03-13 | 17 GNRN O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-04-26 | 18 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-04-26 | 19 ARAA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-09-13 | 20 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-09-17 | 21 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-09-17 | 22 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2019-09-27 | 23 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2019-09-27 | 24 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-09-27 | 25 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-03-25 | 26 TROA I:Incoming Correspondence |
| TEAS AMENDMENT OF USE RECEIVED | 2020-03-25 | 27 EAAU I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-03-27 | 28 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-03-27 | 29 TEME I:Incoming Correspondence |
| USE AMENDMENT FILED | 2020-03-27 | 30 IUAF S: |
| AMENDMENT TO USE PROCESSING COMPLETE | 2020-03-27 | 31 AUPC I:Incoming Correspondence |
| USE AMENDMENT ACCEPTED | 2020-04-01 | 32 IUAA P: |
| APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | 2020-04-01 | 33 CNTA O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | 2020-04-02 | 34 AAUA E:E-Mail |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2020-04-09 | 35 PREV O:Outgoing Correspondence |
| REGISTERED-SUPPLEMENTAL REGISTER | 2020-05-12 | 36 R.SR A:Allowance for Publication |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-08-05 | 37 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-08-05 | 38 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-08-05 | 39 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2020-08-05 | 40 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-08-05 | 41 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-08-05 | 42 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-08-07 | 43 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-08-07 | 44 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2020-08-07 | 45 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-08-07 | 46 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-04-28 | 47 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-04-28 | 48 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-04-28 | 49 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-04-28 | 50 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-04-28 | 51 CHAN I:Incoming Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 